Skip to search formSkip to main contentSkip to account menu

BE 22179

Known as: Alanine, N-((3-hydroxy-2-quinolinyl)carbonyl)cysteinylglycyl-N-methylcysteinyl-2,3-didehydro-N-methylthio-, bimol. (4-1'),(4'-1)-(thio lactone), cyclic (3-3')-disulfide, BE-22179 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PeptidesTopoisomerase II Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Protection by Conformationally Restricted Mobility: First Solid-Phase Synthesis of Triostin[emsp14]A
Triostin A (Figure 1) belongs to a family of peptide antibiotics produced by marine bacteria. Triostins (A, B, and C) were… 
1994
1994
A new topoisomerase II inhibitor, BE-22179, produced by a streptomycete. I. Producing strain, fermentation, isolation and biological activity.
A new topoisomerase II inhibitor, designated BE-22179, was isolated from the culture broth of Streptomyces sp. A22179, which… 
1994
1994
Inhibition of Topoisomerase II by a Novel Antitumor Cyclic Depsipeptide, BE‐22179
BE‐22179, a novel cyclic depsipeptide antibiotic having two 3‐hydroxyquinoline moieties, inhibited the DNA‐relaxing activity of… 
1972
1972
Cytotoxic compounds. XIV. Reactions of the bismethanesulphonates of 3-arylthiopropane-1,2-diols and of 2-arylthiopropane-1,3-diols with nucleophiles.
The products formed in the title reactions have been examined by 1H n.m.r. spectroscopy. The aryl group was p-methoxy-, p… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)